Pharmafile Logo

Extraordinary lives: advancing change in rare diseases

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. On this day across the globe, the rare disease community and its supporters come together to call for more equitable access to social opportunity, treatment and care for people living with a rare disease, their families and carers.

In support of Rare Disease Day, we are extending the conversation beyond the day itself with a two-part panel discussion that draws on the experiences from different perspectives, including pharma, research, patients and their families and healthcare professionals working within the rare disease field.

We will be releasing Parts 1 and 2 on 14 March and 21 March on LinkedIn and our Instagram channels: @mededlucid @wearelucidgroup, and we’ll also be publishing a highlights report.

This is a short trailer from our recent discussions with experts, to make sure you don’t miss out on the full version follow us now.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group sets the vision for its team of committed Mental Health First Aiders

As we approach World Mental Health Day, Lucid's team of Mental Health First Aiders reflect on their training and set the vision for how they will be supporting the organisation...

The Lucid Group Wellbeing Champions embark on their MHFA training

A mentally sound organisation is good for talent and business. Statistics from Mental Health First Aid (MHFA) England point out to mental health illness (such as depression or anxiety) accounting...

Lucid Group Nurtures Talent. Always.

Lockdown and Covid-19 have not stopped us from nurturing and developing the amazing talent we have at Lucid. Growth is at the heart of #LucidLife.So if you're looking for a place...

Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards

Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in...

It’s been ten magical years at Lucid Group for Emma Cox

August marks a special work anniversary for Emma Cox who is celebrating 10 years at Lucid Group!Over the past decade, Emma has demonstrated resilience, tenacity and grit with a disarming...

Lucid Group: Digital Delivery in Lockdown

Standing still is the fastest way of moving backwards in today's world. That's why we've been moving forward and transforming at every step to make sure we can continue to...

Lucid Group scoop a win and a high commendation at Communiqué 2020

Due to the COVID-19 pandemic, this year’s Communiqué awards was a virtual ceremony, celebrating some of the most inspiring work and people in medical communications.Lucid Group were delighted to come...

PHARMA POST COVID-19: REVOLUTION OR EVOLUTION?

Post-COVID-19 thinking: outputs from a thought leader forumOn 14 May 2020, a group of industry experts across pharma and biotech Zoomed together to share reflections on the impact of COVID-19...

Lucid Group are shortlisted in three categories for Communiqué 2020

Lucid’s talent for creating industry-leading programmes is clear to see as they celebrate three of its campaigns being shortlisted for Communiqué 2020, as well as making the finals forThe Real...

Taking the ‘free’ out of ‘freelance’ and bringing it in-house

In this month’s Smart Thinking blog on PMLive.com, Stephanie Wasek, now a permanent principal medical writer at Lucid Group, draws her experience to discuss the highs and lows of being...